Literature DB >> 36245661

Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD.

John D Imig1.   

Abstract

Entities:  

Keywords:  basic science; chronic kidney disease; mineral aggregates; nanocrystals; nephrocalcinosis; osteopontin; phosphate; solubility

Mesh：

Substances：

Year:  2022        PMID： 36245661      PMCID： PMC9528367          DOI： 10.34067/KID.0004292022

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  12 in total

Review 1.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

2.  Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).

Authors:  Peter S N Rowe; Ian R Garrett; Patricia M Schwarz; David L Carnes; Eileen M Lafer; Gregory R Mundy; Gloria E Gutierrez
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

Review 3.  Contribution of phosphate and FGF23 to CKD progression.

Authors:  Kyle P Jansson; Alan S L Yu; Jason R Stubbs
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-11       Impact factor: 3.416

Review 4.  Epidemiology of chronic kidney disease: an update 2022.

Authors:  Csaba P Kovesdy
Journal:  Kidney Int Suppl (2011)       Date:  2022-03-18

Review 5.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

Review 6.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

7.  Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney.

Authors:  Talya Wolak; HyunJu Kim; Yuelan Ren; Jason Kim; Nosratola D Vaziri; Susanne B Nicholas
Journal:  Kidney Int       Date:  2009-04-08       Impact factor: 10.612

Review 8.  Inherited conditions resulting in nephrolithiasis.

Authors:  Bernd Hoppe; Cristina Martin-Higueras
Journal:  Curr Opin Pediatr       Date:  2020-04       Impact factor: 2.856

9.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

10.  Assessment of urinary osteopontin in association with podocyte for early predication of nephropathy in diabetic patients.

Authors:  Abdulrahman L Al-Malki
Journal:  Dis Markers       Date:  2014-05-04       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.